Attovia Therapeutics CFO reports stock option holdings
Attovia Therapeutics, Inc. reported initial insider holdings showing a Chief Financial Officer with two stock option awards over its common stock.
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported initial insider holdings showing a Chief Financial Officer with two stock option awards over its common stock. One option covers 215,285 underlying shares at an exercise price of $3.5302 per share, expiring on November 13, 2034. The second option covers 80,731 underlying shares at an exercise price of $4.9237 per share, expiring on May 17, 2035. Each option vests over four years, with 25% of the underlying shares vesting on an initial vesting date and the remaining 75% vesting in 1/48th monthly installments over three years, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Attovia Therapeutics, Inc.
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 296,016 contracts (Direct)
Footnotes (2)
- F1. The option vests over a four-year period. The vesting schedule is as follows: 25% of the shares of common stock underlying the stock option vested on October 14, 2025, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three-years, subject to continued service to the Issuer through such date.
- F2. The option vests over a four-year period. The vesting schedule is as follows: 25% of the shares of common stock underlying the stock option vested on May 18, 2026, and an additional 1/48th of the total shares underlying the stock option vest in equal monthly installments over three-years, subject to continued service to the Issuer through such date.
Key Figures
Underlying Shares (Option 1): 215,285 shares
Exercise Price (Option 1): $3.5302 per share
Underlying Shares (Option 2): 80,731 shares
+3 more
6 metrics
Underlying Shares (Option 1)
215,285 shares
Common stock underlying stock option with $3.5302 exercise price
Exercise Price (Option 1)
$3.5302 per share
Stock option expiring November 13, 2034
Underlying Shares (Option 2)
80,731 shares
Common stock underlying stock option with $4.9237 exercise price
Exercise Price (Option 2)
$4.9237 per share
Stock option expiring May 17, 2035
Initial Vesting Portion
25%
Portion of underlying shares vesting at initial vesting date for each option
Ongoing Vesting Rate
1/48th monthly
Remaining shares vest in equal monthly installments over three years
Key Terms
Stock Option (Right to Buy), underlying security, exercise price, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
underlying security financial
"underlying_security_title: Common Stock underlying the option"
exercise price financial
"conversion_or_exercise_price of $3.5302 and $4.9237 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"options expiring on November 13, 2034 and May 17, 2035"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting schedule financial
"The option vests over a four-year period with a specified vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider holdings does Attovia Therapeutics (ATTO) disclose in this Form 3?
The filing shows a Chief Financial Officer holding two stock options over Attovia common stock, covering 215,285 and 80,731 underlying shares with specified exercise prices and expiration dates.
What are the exercise prices of the Attovia Therapeutics (ATTO) CFO’s stock options?
The options have exercise prices of $3.5302 and $4.9237 per share. These prices represent the cost per share to acquire Attovia common stock upon exercising the respective stock options.
What are the expiration dates of the Attovia Therapeutics (ATTO) CFO’s stock options?
The options expire on November 13, 2034 and May 17, 2035. After these dates, the right to exercise the respective options and purchase Attovia common shares lapses.
How do the Attovia Therapeutics (ATTO) stock options reported here vest?
Each option vests over four years: 25% of underlying shares vested on an initial date, with the remaining 75% vesting in equal 1/48th monthly installments over three years, contingent on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
